311 related articles for article (PubMed ID: 25611378)
1. The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape.
Modelska A; Turro E; Russell R; Beaton J; Sbarrato T; Spriggs K; Miller J; Gräf S; Provenzano E; Blows F; Pharoah P; Caldas C; Le Quesne J
Cell Death Dis; 2015 Jan; 6(1):e1603. PubMed ID: 25611378
[TBL] [Abstract][Full Text] [Related]
2. mRNA structural elements immediately upstream of the start codon dictate dependence upon eIF4A helicase activity.
Waldron JA; Tack DC; Ritchey LE; Gillen SL; Wilczynska A; Turro E; Bevilacqua PC; Assmann SM; Bushell M; Le Quesne J
Genome Biol; 2019 Dec; 20(1):300. PubMed ID: 31888698
[TBL] [Abstract][Full Text] [Related]
3. eIF4B stimulates eIF4A ATPase and unwinding activities by direct interaction through its 7-repeats region.
Andreou AZ; Harms U; Klostermeier D
RNA Biol; 2017 Jan; 14(1):113-123. PubMed ID: 27858515
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase.
Steinhardt JJ; Peroutka RJ; Mazan-Mamczarz K; Chen Q; Houng S; Robles C; Barth RN; DuBose J; Bruns B; Tesoriero R; Stein D; Fang R; Hanna N; Pasley J; Rodriguez C; Kligman MD; Bradley M; Rabin J; Shackelford S; Dai B; Landon AL; Scalea T; Livak F; Gartenhaus RB
Blood; 2014 Dec; 124(25):3758-67. PubMed ID: 25320244
[TBL] [Abstract][Full Text] [Related]
5. eIF4B stimulates translation of long mRNAs with structured 5' UTRs and low closed-loop potential but weak dependence on eIF4G.
Sen ND; Zhou F; Harris MS; Ingolia NT; Hinnebusch AG
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10464-72. PubMed ID: 27601676
[TBL] [Abstract][Full Text] [Related]
6. WD Repeat Domain 77 Protein Regulates Translation of E2F1 and E2F3 mRNA.
Altayyar MA; Sheng X; Wang Z
Mol Cell Biol; 2020 Nov; 40(24):. PubMed ID: 33020149
[TBL] [Abstract][Full Text] [Related]
7. eIF4A alleviates the translational repression mediated by classical secondary structures more than by G-quadruplexes.
Waldron JA; Raza F; Le Quesne J
Nucleic Acids Res; 2018 Apr; 46(6):3075-3087. PubMed ID: 29471358
[TBL] [Abstract][Full Text] [Related]
8. eIF4A1-dependent mRNAs employ purine-rich 5'UTR sequences to activate localised eIF4A1-unwinding through eIF4A1-multimerisation to facilitate translation.
Schmidt T; Dabrowska A; Waldron JA; Hodge K; Koulouras G; Gabrielsen M; Munro J; Tack DC; Harris G; McGhee E; Scott D; Carlin LM; Huang D; Le Quesne J; Zanivan S; Wilczynska A; Bushell M
Nucleic Acids Res; 2023 Feb; 51(4):1859-1879. PubMed ID: 36727461
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death 4 mechanism of action: The model to be updated?
Vikhreva PN; Kalinichenko SV; Korobko IV
Cell Cycle; 2017 Oct; 16(19):1761-1764. PubMed ID: 28853972
[TBL] [Abstract][Full Text] [Related]
10. S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth.
Dorrello NV; Peschiaroli A; Guardavaccaro D; Colburn NH; Sherman NE; Pagano M
Science; 2006 Oct; 314(5798):467-71. PubMed ID: 17053147
[TBL] [Abstract][Full Text] [Related]
11. Monitoring RNA restructuring in a human cell-free extract reveals eIF4A-dependent and eIF4A-independent unwinding activity.
O'Sullivan MH; Fraser CS
J Biol Chem; 2023 Jul; 299(7):104936. PubMed ID: 37331603
[TBL] [Abstract][Full Text] [Related]
12. Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor.
Iwasaki S; Floor SN; Ingolia NT
Nature; 2016 Jun; 534(7608):558-61. PubMed ID: 27309803
[TBL] [Abstract][Full Text] [Related]
13. Migration of Small Ribosomal Subunits on the 5' Untranslated Regions of Capped Messenger RNA.
Shirokikh NE; Dutikova YS; Staroverova MA; Hannan RD; Preiss T
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510048
[TBL] [Abstract][Full Text] [Related]
14. Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules.
Singh K; Lin J; Lecomte N; Mohan P; Gokce A; Sanghvi VR; Jiang M; Grbovic-Huezo O; Burčul A; Stark SG; Romesser PB; Chang Q; Melchor JP; Beyer RK; Duggan M; Fukase Y; Yang G; Ouerfelli O; Viale A; de Stanchina E; Stamford AW; Meinke PT; Rätsch G; Leach SD; Ouyang Z; Wendel HG
Cancer Res; 2021 Apr; 81(8):2002-2014. PubMed ID: 33632898
[TBL] [Abstract][Full Text] [Related]
15. Targeting Oncogene mRNA Translation in B-Cell Malignancies with eFT226, a Potent and Selective Inhibitor of eIF4A.
Thompson PA; Eam B; Young NP; Fish S; Chen J; Barrera M; Howard H; Sung E; Parra A; Staunton J; Chiang GG; Gerson-Gurwitz A; Wegerski CJ; Nevarez A; Clarine J; Sperry S; Xiang A; Nilewski C; Packard GK; Michels T; Tran C; Sprengeler PA; Ernst JT; Reich SH; Webster KR
Mol Cancer Ther; 2021 Jan; 20(1):26-36. PubMed ID: 33037136
[TBL] [Abstract][Full Text] [Related]
16. Role of p70S6K1-mediated phosphorylation of eIF4B and PDCD4 proteins in the regulation of protein synthesis.
Dennis MD; Jefferson LS; Kimball SR
J Biol Chem; 2012 Dec; 287(51):42890-9. PubMed ID: 23105104
[TBL] [Abstract][Full Text] [Related]
17. FGFR1-Activated Translation of WNT Pathway Components with Structured 5' UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation Initiation.
Nguyen TM; Kabotyanski EB; Dou Y; Reineke LC; Zhang P; Zhang XH; Malovannaya A; Jung SY; Mo Q; Roarty KP; Chen Y; Zhang B; Neilson JR; Lloyd RE; Perou CM; Ellis MJ; Rosen JM
Cancer Res; 2018 Aug; 78(15):4229-4240. PubMed ID: 29844125
[TBL] [Abstract][Full Text] [Related]
18. A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A.
Yang HS; Cho MH; Zakowicz H; Hegamyer G; Sonenberg N; Colburn NH
Mol Cell Biol; 2004 May; 24(9):3894-906. PubMed ID: 15082783
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor protein Pdcd4 inhibits translation of p53 mRNA.
Wedeken L; Singh P; Klempnauer KH
J Biol Chem; 2011 Dec; 286(50):42855-62. PubMed ID: 22033922
[TBL] [Abstract][Full Text] [Related]
20. RNA helicase EIF4A1-mediated translation is essential for the GC response.
Screen M; Matheson LS; Howden AJ; Strathdee D; Willis AE; Bushell M; Sansom O; Turner M
Life Sci Alliance; 2024 Feb; 7(2):. PubMed ID: 38011999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
